Table 1 MSD prevalence of the spine segments
# | First author, year | Country | Sample size | Lower back | Neck | Upper back | Overall MSDc | |||
|---|---|---|---|---|---|---|---|---|---|---|
Prevalence % (95% CI)b | point | 12-month | point | 12-month | point | 12-month | 12-month (†point) | |||
1 | Adewumi-Gunn, 2016 [39] | US | 22 | 36% (19.6–57.1) | – | – | – | – | – | – |
2 | Amodeo, 2004 [40] | FRd | 389 | – | 47% (41.6–51.5) | – | 37% (31.9–41.4) | – | 36% (31.4–40.9) | – |
3 | Aweto, 2015 [41] | NI | 299 | – | 76% (71.1–80.7) | – | 46% (40.6–51.8) | – | 5% (2.7–7.8) | 76% (70.4–80.1) |
4 | Bradshaw, 2011 [13] | UKd | 147 | 42% (34.5–50.3) | – | 31% (24.3–39.2) | – | 27% (20.6–34.9) | – | – |
5 | Cruz, 2015 [42] | POd | 30 | 100% (88.4–100) | – | 77% (58.8–88.5) | – | 17% (6.9–34) | – | – |
6 | De Smet, 2009 [43] | BEd | 145 | – | – | – | – | – | – | 41% (33.0–48.8)†|
7 | Deschamps, 2014 [44] | FRd | 199 | 27% (20.9–33.2) | – | 20% (14.7–25.7) | – | – | – | 67% (60–73)†|
8 | Douwes, 2001 [45] | NLd | 280 | 23% (18.3–28.1) | 34% (28.3–39.3) | – | 52% (46.3–57.9) | – | – | 49% (42.8–54.4) |
9 | Hassan, 2015 [14] | EG | 80 | – | 13% (6.7–21.7) | – | 9% (4.0–17.2) | – | – | – |
10 | Mahdavi, 2013 [46] | IR | 172 | – | 59% (51.3–65.8) | – | 52% (44.9–59.7) | – | 40% (32.5–47) | – |
11 | Mandiracioglu, 2009 [47] | TU | 1284 | – | 27% (24.7–29.5) | – | – | – | – | 32% (29.4–34.5) |
12 | Mussi, 2008 [48] | BR | 220 | – | 39% (32.9–45.7) | – | 47% (40.3–53.4) | – | – | 71% (64.6–76.5) |
13 | O’Loughlin, 2010 [50] | AS | 238 | – | 71% (65.4–76.8) | – | – | – | – | – |
14 | Omokhodion, 2009 [51] | NI | 355 | 19% (15.1–23.3) | – | – | – | – | – | – |
15 | Puckree, 2009 [52] | SF | 75 | 39% (28.4–50) | – | – | – | 11% (5.3–19.9) | – | 60% (48.7–70.4)†|
16 | Schneider, 2006 [25] | GEd | 26 | 46% (28.8–64.6) | 70% (49.9–83.7) | – | – | – | – | – |
17 | Tsigonia, 2009 [38] | GRd | 102 | – | 53% (43.3–62.3) | – | 58% (48.1–67) | – | – | – |
18 | Veiersted, 2008 [7] | NOd | 188 | – | – | 28% (22.2–35) | 47% (40.3–54.5) | – | – | – |
Range (min-max in %) | 19–100% | 13–76% | 20–77% | 9–58% | 11–27% | 5–40% | 32–76% | |||
No of studies with data on prevalence | n = 16 | n = 11 | n = 6 | n = 7 | ||||||